Prevenar 13, Injektionssuspension in einer Fertigspritze

7680601290012 CH-60129 Injektionssuspension
Prevenar 13, Injektionssuspension in einer Fertigspritze
Prevenar 13, Injektionssuspension in einer Fertigspritze
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1 x 0.5 ml
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
22/04/2026
Summary of Product Characteristics
Français
22/04/2026
Summary of Product Characteristics
Italien
22/04/2026

Detailed composition

Substance Quantity Type Category
polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 6A conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 6B conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.4 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 7F conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 9V conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 18C conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 19A conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 19F conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 23F conjugata cum proteino corynebacteriae diphtheriae CRM 197
2.2 UG Substance Wirkstoff (Principe actif)
polysaccharida
30.8 UG Substance WIIS
proteinum corynebacteriae diphtheriae CRM 197
- Substance WIIS
aluminium
- Substance HNIDK
aluminii phosphas
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrium
1.67 MG Substance HBESI
acidum succinicum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 77.70
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2011

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
60129
Drug name
Prevenar 13, Injektionssuspension in einer Fertigspritze
Galenic form
INJFS
ATC Code
J07AL02
Authorization status
Z
Dispensing category
B
First authorization
12/08/2010
Authorization expiration date
31/12/9999
IT Number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Pneumokokken-Infektionen der Serotypen 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F

Package details

Description (FR)
PREVENAR 13 av aiguilles ser pré 0.5 ml
Description (DE)
PREVENAR 13 mit Nadeln Fertspr 0.5 ml
Market launch
12/08/2010
Narcotic (BTM)
No

Other package sizes (1)

PREVENAR 13 av aiguilles 10 ser pré 0.5 ml
10 x 0.5 ml FESP
GTIN: 7680601290029
View
Buy us a coffee Explore the data